Vir and Alnylam expand collaboration to advance investigational RNAi therapeutics targeting host factors fof COVID-19
On Apr. 2, 2020, Vir Biotech and Alnylam Pharma announced an expansion to their broad multi-target existing collaboration…
University Hospital Basel, Switzerland transfused first two COVID-19 patients with INTERCEPT treated Coronavirus convalescent plasma
On Apr. 2, 2020, Cerus announced that the University Hospital Basel transfused the first two COVID-19 patients with…
Amgen and Adaptive Biotechnologies to develop a therapeutic to prevent or treat COVID-19
On Apr. 2, 2020, Amgen and Adaptive Biotechnologies announced a collaboration aimed at helping address the COVID-19 pandemic….
Vanda Pharma announced initiation of FDA approved clinical study of Tradipitant patients with severe COVID-19 pneumonia
On Apr. 2, 2020, Vanda Pharmaceuticals announced initiation of clinical study, ODYSSEY VLY-686-3501, in hospitalized patients with COVID-19….
BioAegis accelerated multiple clinical trial submissions for severe COVID-19 pneumonia patients
On Apr. 2, 2020, BioAegis Therapeutics announced that it was preparing to evaluate plasma gelsolin replacement in severe…
Collaborative effort brings new COVID-19 treatment approach to Western New York
On Apr. 2, 2020, Roswell Park Comprehensive Cancer Center and the University at Buffalo (UB) launched a collaborative…
Fred Hutch team launched hunt for coronavirus antibodies
On Apr. 2, 2020, a team of scientists at Fred Hutchinson Cancer Research Center in Seattle began searching…
GW Hospital used VR technology to see into COVID-19 patientï¾’s lungs
On Apr. 2, 2020, George Washington University Hospital announed it had used Virtual Reality technology to see into…
Adaptive Biotechnologies and Amgen announced collaboration to address COVID-19 pandemic
On Apr. 2, 2020, Amgen and Adaptive Biotechnologies announced a collaboration aimed at helping address the COVID-19 pandemic….
UW-Madison, FluGen and Bharat Biotech announced development of CoroFlu, a coronavirus vaccine
On Apr. 2, 2020, an international collaboration of virologists at the University of Wisconsinï¾–Madison and the vaccine companies…
Philips enabled hospitals and GPs to remotely screen and monitor patients with COVID-19
On Apr. 1, 2020, Philips announced that it can help general practitioners and healthcare institutions manage the increased…
Adamis Pharma announced production of hospial sanitizers by subsidiary US Compounding to aid in COVID-19 Pandemic
On Apr. 1, 2020, Adamis Pharma announced that its wholly owned drug outsourcing facility, US Compounding Inc. (USC),…
Amgen established Amgen Astellas BioPharma as wholly-owned affiliate In Japan
On Apr. 1, 2020, Amgen announced it had consummated the purchase from Astellas of 49% of shares of…
Innovation Pharma received data supporting Brilacidinï¾’s direct inhibition of SARS-CoV-2
On Apr. 1, 2020, Innovation Pharma it had received data supporting Brilacidinï¾’s direct inhibition of SARS-CoV-2, the novel…
Paratek Pharma announced BARDA funding for onshoring the manufacturing supply for NUZYRA (omadacycline)
On Apr. 1, 2020, Innovation Pharma announced BARDA has initiated funding to support the onshoring of Paratek manufacturing…
Henry Schein named exclusive distributor of second point-of-care antibody rapid test
On Apr. 1, 2020, Henry Schein announced that it will serve as the exclusive distributor in the U.S….
Diffusion Pharma announced evaluating TSC against Acute Respiratory Distress Syndrome in COVID-19 patients
On Apr. 1, 2020, Diffusion Pharmaceuticals announced it had begun a cooperative research effort with University of Virginia…
PATH-led study found commercially available reference diagnostic detected malaria with whole blood sample
On Apr. 1, 2020, new evidence in The American Journal of Tropical Medicine and Hygiene suggested that the…
Early study of COVID-19 patients showed high mortality rate
On Apr. 1, 2020, a study of 24 of the most critically ill patients with COVID-19, early on…
NIH researchers discovered gene for rare disease of excess bone tissue growth
On Mar. 31, 2020, NIH researchers announced they had discovered a second gene that causes melorheostosis, a rare…
Philips to fulfill contract with the HHS for the delivery of 10,000 Trilogy Universal units with accelerate delivery to the SNS
On Mar. 31, 2020, Philips announced that it was fully committed to fulfill the contract with the HHS…
Vaxart provided update on its oral COVID-19 vaccine program
On Mar. 31, 2020, Vaxart announced it had produced five COVID-19 vaccine candidates for testing in its preclinical…
Amyris scaled up in response to high need for hand sanitizer and wipe products
On Mar. 31, 2020, Amyris announced that initial production of its hand sanitizer has started with Allure Labs…
Emergent BioSolutions signed agreement with Novavax to manufacture NanoFlu
On Mar. 31, 2020, Emergent BioSolutions announced an agreement with Novavax whereby Emergent will provide molecule-to-market contract development…
Chembio announced launch of DPP COVID-19 serological point-of-care test
On Mar. 31, 2020, Chembio Diagnostics announced the U.S. launch of the rapid DPP COVID-19 serological point-of-care test…
Luminex received BARDA contract to support development of second, rapid SARS-CoV-2 test
On Mar. 31, 2020, Luminex announced it had received $642,450 in funding from the Biomedical Advanced Research and…
VBI Vaccines announced collaboration with National Research Council of Canada to develop pan-Coronavirus vaccine candidate
On Mar. 31, 2020, VBI Vaccines announced a collaboration with the National Research Council of Canada (NRC) to…
NIH-funded studies showed stents and surgery no better than medication, lifestyle changes at reducing cardiac events
On Mar. 30, 2020, invasive procedures such as bypass surgery and stentingï¾—commonly used to treat blocked arteriesï¾—were no…
Bayer increased Germany’s COVID-19 analysis capacity by several thousand tests per day
On Mar. 30, 2020, Bayer announced it had made available more than 40 virus diagnostics devices from its…
The Institute for Molecular Medicine in Finland launched a COVID-19 Host Genetics Initiative
On Mar. 30, 2020, the Institute for Molecular Medicine in Finland (FIMM) announced it had launched a COVID-19…